EuroSIDA Publications 2019

1 Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus-infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study. L Shepherd, L Ryom, M Law, K Petoumenos, C Ingrid Hatleberg, A d’Arminio Monforte, C Sabin, M Bower, F Bonne, P Reiss, S de Wit, C Pradier, R Weber, W el-Sadr, J Lundgren, A Mocroft. On behalf of the D:A:D Study group
Clin Infect Dis. 2019;68(4):650-657. Abstract

2 Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA. Amele S, Peters L, Sluzhynska M, Yakovlev A, Scherrer A, Domingo P, Gerstoft J, Viard JP, Gisinger M, Flisiak R, Bhaghani S, Ristola M, Leen C, Jablonowska E, Wandeler G, Stellbrink H, Falconer K, D'Arminio Monforte A, Horban A, Rockstroh JK, Lundgren JD, Mocroft A; EuroSIDA study group.
HIV Med. 2019;20(4):264-273. Abstract

3 Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies. Wandeler, G., Mauron, E., Atkinson, A., Dufour, J-F., Kraus, D., Reiss, P., Peters, L., Dabis, F., Fehr, J., Bernasconi, E., van der Valk, M., Smit, C., Gjærde, L.K., Rockstroh, J., Neau, D., Bonnet, F., Rauch, A., on behalf of the Swiss HIV Cohort Study, Athena Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort
J Hepatol. 2019;71(2):274-280. Epub 2019 Apr 6. Abstract

4 Use of contemporary protease inhibitors Darunavir and risk of incident chronic kidney disease in HIV-positive persons; the D:A:D Study
Lene Ryom, Jens Dilling Lundgren, Peter Reiss,, Ole Kirk, Matthew Law, Mike Ross, Phillip Morlat, Christoph Andreas Fux, Eric Fontas, Stephane De Wit, Antonella d’Arminio Monforte, Wafaa El Sadr, Andrew Phillips, Camilla Ingrid Hatleberg, Caroline Sabin and Amanda Mocroft for the D:A:D Study Group
The Journal of Infectious Diseases 2019. Abstract

5 Serious clinical events in HIV-positive persons with chronic kidney disease (CKD). Ryom L, Lundgren JD, Law M, Kirk O, El-Sadr W, Bonnet F, Weber R, Fontas E, Monforte AD, Phillips A, Reiss P, de Wit S, Hatleberg CI, Sabin C, Mocroft A; D:A:D study group.
AIDS. 2019.  [Epub ahead of print] Abstract

6 Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study
Camilla Ingrid Hatleberg, Lene Ryom, David Kamara, Stephane De Wit, MatthewLaw, Andrew Phillips, Peter Reiss, Antonella D'Arminio Monforte, AmandaMocroft, Christian Pradier, Ole Kirk, Helen Kovari, Fabrice Bonnet, Wafaa El-Sadr, Jens D. Lundgren, CarolineSabin, for the D:A:D Study Group   
EClinicalMedicine Volume 13, P91-100,  2019. Abstract

7 Uptake and effectiveness of two-drug compared to three-drug antiretroviral Regimens among HIV-positive Individuals in Europe
Neesgaard B, Pelchen-Matthews A, Ryom L, Florence E, Peters L, Roen A, Svedhem V, Clarke A, Benfield T, Mitsura V, Moreno S, Beniowski M, Begovac J, Matulionyte R, Trofimova T, Elbirt D, Kundro M, Vullo V, Behrens G, Staub T, Ragone L, Vannappagari V, Lundgren J, Mocroft A; EuroSIDA study.
AIDS. 2019;33(13):2013-2024.  Abstract

8 The EuroSIDA study: 25 years of scientific achievements​. K Laut,  O Kirk, J Rockstroh ,A Phillips, B Ledergerber, J Gatell  B Gazzard, A Horban, I Karpov, M Losso, A d’Arminio Monforte, C Pedersen, M Ristola, P Reiss, AU Scherrer, S de Wit, I Aho, LD Rasmussen, V Svedhem, G Wandeler, C Pradier, N Chkhartishvili, R Matulionyte, C Oprea, JD Kowalska, J Begovac, JM Miró, G Guaraldi, R Paredes, D Raben, D Podlekareva, L Peters, JD Lundgren, A Mocroft for the EuroSIDA study.
HIV Med. 2020;21(2):71-83. Epub 2019 Oct 24. Abstract


Total Publications December 2019: 294